Description: ASPI is an advanced materials company dedicated to the development of technology and processes that will allow for the production of isotopes that may be used in several industries. We have an exclusive license to use proprietary technology, the Aerodynamic Separation Process ("ASP technology") for the production, distribution, marketing and sale of all isotopes.
Home Page: aspisotopes.com
ASPI Technical Analysis
1101 Pennsylvania Avenue NW
Washington,
DC
20004
United States
Phone:
202 756 2245
Officers
| Name | Title |
|---|---|
| Mr. Paul Elliot Mann C.F.A. | President, CEO & Executive Chairman |
| Mr. Robert Ainscow | Chief Operating Officer |
| Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. | CTO & Director |
| Ms. Heather Kiessling | Chief Financial Officer |
| Mr. Hendrik T. van Wyk | Head of Engineering |
| Dr. Xandra van Heerden Ph.D. | Head of Research & Development |
| Dr. Gerdus Kemp M.D., Ph.D. | Medical Director & CEO of Pet Labs |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Materials |
|---|---|
| GIC Group: | Materials |
| GIC Industry: | Metals & Mining |
| GIC Sub-Industry: | Diversified Metals & Mining |
| Forward PE: | 54.3478 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 8.0624 |
| Price-to-Sales TTM: | 135.8965 |
| IPO Date: | 2022-11-10 |
| Fiscal Year End: | December |
| Full Time Employees: | 76 |